Lak Shin Jeong is an academic researcher from Seoul National University. He completed his PhD studies in Medicinal Chemistry at the University of Georgia. After post-doctoral training at the U.S. National Institutes of Health (1993–1995), he joined Ewha Womans University as a Professor (1995–2013), and led the NRF WCU Type-1 project (2008–2013). He has been a professor of Pharmacy at Seoul National University (SNU) since 2013, The author has an h-index of 36, and has co-authored 315 publications. Research field include: Adenosine Receptor Ligand Development Research; DNA methyltransferase inhibitor development studies; Mechanism-based inhibitors of S-adenosylhomocysteine hydrolase; Development of treatments for AIDS, Herpes, Hepatitis B/C; Development of Next-Generation Selenonucloside.